Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04649346
Other study ID # 201907019RINC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 25, 2020
Est. completion date July 30, 2021

Study information

Verified date October 2020
Source National Taiwan University Hospital
Contact Liu Chih Min
Phone 02-23123456
Email liu.chihmin@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The difference of oropharyngeal leak pressure and sealing pressure between new supraglottic airway devices.


Description:

In this clinical study, investigators want to discuss the issue that oropharyngeal leak pressure and sealing condition with different SGA including air-Q、i-gel、LMA-supreme、AMBU auragain 、ProSeal LMA and other new SGAs. In the perioperative period, investigators documented respiratory function data including oropharyngeal leak pressure and peak airway pressure in these randomly selected SGA. Oropharyngeal leak pressure was measured by closing the expiratory valve of the circle system at fixed O2 flow 3L/min and noting the airway pressure at which the dial on a calibrated aneroid manometer reached equilibrium. investigators wanted to compared the respiratory function between air-Q、i-gel、LMA-supreme、AMBU auragain、ProSeal LMA and other new SGAs during surgery and postoperative care unit.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date July 30, 2021
Est. primary completion date July 30, 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 80 Years
Eligibility Inclusion criteria: 1. 20-80 years old. 2. ASA physical status I or II . 3. Without major organ dysfunction like heart, liver, brain, lung, kidney function failure. Exclusion criteria: 1. BMI> 35 kg/m2. 2. Risk of aspiration(NPO clear water> 2 hours, solid foods > 8 hours). 3. Difficult airway like head and neck tumor or airway tumor. 4. Limited mouth opening (<2cm). 5. major organ dysfunction including heart, liver, brain, lung, kidney function failure. 6. Major surgery including open heart surgery, laparotomy general surgery, open chest surgery.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oropharyngeal leak pressures oropharyngeal leak pressure units ( cmH2O ) 10 minutes
Secondary 1. The participant's head and neck position 2. The number of attempts required for SGA insertion 3. Ease of gastric tube placement 4. The ventilation score The participant's head and neck position (neutral/extension/flexion/rotation)
The number of attempts required for SGA insertion (1/2/3/tracheal intubation)
Ease of gastric tube placement (success/failure/Leak)
The ventilation score was scored from 0 to 3 based on three criteria:
(1) No leakage with an airway pressure of > 15 cm H2O (2) Bilateral chest excursions with a peak inspiratory pressure of > 20 cm H2O (3) A Square Wave Capnography with each item scoring 0 or 1 point. Thus, if all three criteria were satisfied, the ventilation score was 3.
180 minutes
See also
  Status Clinical Trial Phase
Completed NCT03933644 - Ambu Aura GainTM Guided vs Non Guided in Edentulous Ambu Aura GainTM Without Gastric Tube in Endontolous Patient N/A